DOCSLIB.ORG
  • Sign Up
  • Log In
  • Upload
  • Sign Up
  • Log In
  • Upload
  • Home
  • »  Tags
  • »  Corticorelin

Corticorelin

  • The Activation of the Glucagon-Like Peptide-1 (GLP-1) Receptor by Peptide and Non-Peptide Ligands

    The Activation of the Glucagon-Like Peptide-1 (GLP-1) Receptor by Peptide and Non-Peptide Ligands

  • List of Approved Ndas for Biological Products That Were Deemed to Be Blas on March 23, 2020

    List of Approved Ndas for Biological Products That Were Deemed to Be Blas on March 23, 2020

  • Corticorelin Acetate, a Synthetic Corticotropin-Releasing Factor with Preclinical Antitumor Activity, Alone and with Bevacizumab, Against Human Brain Tumor Models

    Corticorelin Acetate, a Synthetic Corticotropin-Releasing Factor with Preclinical Antitumor Activity, Alone and with Bevacizumab, Against Human Brain Tumor Models

  • BCBSVT Specialty Drug List Effective 2021.07.01.Xlsx

    BCBSVT Specialty Drug List Effective 2021.07.01.Xlsx

  • Preferred Drug List (Formulary)

    Preferred Drug List (Formulary)

  • September 2017 ~ Resource #330909

    September 2017 ~ Resource #330909

  • Michigan Department of Health and Human Services Practitioner and Medical Clinic Fee Schedule Revised: 04/06/2016 January - 2016

    Michigan Department of Health and Human Services Practitioner and Medical Clinic Fee Schedule Revised: 04/06/2016 January - 2016

  • Pharmaceutical Appendix to the Harmonized Tariff Schedule

    Pharmaceutical Appendix to the Harmonized Tariff Schedule

  • CDER List of Licensed Biological Products With

    CDER List of Licensed Biological Products With

  • Michigan Department of Health and Human Services Practitioner and Medical Clinic Fee Schedule July - 2015 Revised: 09/30/2015 9:58:24 AM

    Michigan Department of Health and Human Services Practitioner and Medical Clinic Fee Schedule July - 2015 Revised: 09/30/2015 9:58:24 AM

  • Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued

    Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued

  • Injectable Medication Hcpcs/Dofr Crosswalk

    Injectable Medication Hcpcs/Dofr Crosswalk

  • Stembook 2018.Pdf

    Stembook 2018.Pdf

  • INN Working Document 05.179 Update December 2010

    INN Working Document 05.179 Update December 2010

  • Corticotropin(BAN, Rinn) ⊗

    Corticotropin(BAN, Rinn) ⊗

  • (INN) for Biological and Biotechnological Substances

    (INN) for Biological and Biotechnological Substances

  • (12) Patent Application Publication (10) Pub. No.: US 2010/013.6614 A1 Luo Et Al

    (12) Patent Application Publication (10) Pub. No.: US 2010/013.6614 A1 Luo Et Al

  • Category Catalog CAS Product Name Description Alias/Synonym Application M.F/Formula M.W/Mr

    Category Catalog CAS Product Name Description Alias/Synonym Application M.F/Formula M.W/Mr

Top View
  • Improved Response of Growth Hormone to Growth Hormone
  • Division of Vital Statistics, Mortality Data Table Page 1 of 147
  • International Nonproprietary Names (INN) for Biological and Biotechnological Substances
  • List of Off-Patent, Off-Exclusivity Drugs Without an Approved Generic
  • International Nonproprietary Names for Biological and Biotechnological Substances: a Review17
  • Endocrine Dynamic Function Test Protocols for Use in Neonates and Children Contents
  • Customs Tariff - Schedule
  • Preliminary List of Approved Ndas for Biological Products That Will Be Deemed to Be Blas on March 23, 2020 (Current As of December 31, 2019)
  • (12) United States Patent (Io) Patent No.: US 9,526,824 B2 Ferrari Et Al
  • Anti-Pituitary Antibodies and Susceptible Human Leukocyte
  • U.S. Department of Labor, Office of Workers
  • HA Drug Formulary External List V12 2 161008 (Dated 161006).Xlsx
  • HOSPITAL AUTHORITY DRUG FORMULARY (V17.1 - W.E.F
  • Endocrine Test Protocols
  • State and Specialty Pharmacy Drug Reimbursement Rates
  • International Nonproprietary Names (Inn) for Biological and Biotechnological Substances
  • Wo 2007/044693 A2
  • Advances in Therapeutic Peptides Targeting G Protein-Coupled Receptors


© 2024 Docslib.org    Feedback